SCHEMBL7987509

SCHEMBL7987509

COc1ccc(-c2cncc(-c3cn(CC(C)N(C)C)c4ccc(C#N)cc34)c2)cc1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM1A O60341 2/20 0.44
KDR P35968 2/20 0.40
FLT1 P17948 1/20 0.40
FLT4 P35916 1/20 0.40
MAPKAPK2 P49137 1/20 0.38
PTPN11 Q06124 1/20 0.38
ALPL P05186 1/20 0.37
GRIN1 Q05586 2/20 0.36
GRIN2B Q13224 2/20 0.36
FNTA P49354 1/20 0.36
FNTB P49356 1/20 0.36
PDE4B Q07343 1/20 0.35
XDH P47989 1/20 0.35
PRMT5 O14744 2/20 0.34
WDR77 Q9BQA1 2/20 0.34
MAP4K4 O95819 1/20 0.34
NR3C1 P04150 1/20 0.34
PGR P06401 1/20 0.34
NR3C2 P08235 1/20 0.34
AR P10275 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7976282 0.90 FLT1 (0.40) KDM1AKDRFLT1FLT4FNTA
SCHEMBL7506878 0.89 KDR (0.41) KDM1AKDRFLT1FLT4ALPL
SCHEMBL7507268 0.89 KDR (0.46) KDM1AKDRFLT1FLT4FNTA
SCHEMBL7987165 0.84 KDR (0.51) KDM1AKDRMAPKAPK2PTPN11ALPL
SCHEMBL7511883 0.84 KDR (0.58) KDM1AKDRFLT1FLT4NR3C1
SCHEMBL7503782 0.83 KDR (0.41) KDRFLT1FLT4FNTAFNTB
SCHEMBL7511432 0.83 KDM1A (0.44) KDM1AMAPKAPK2PTPN11ALPLGRIN1
SCHEMBL7987153 0.79 KDR (0.50) KDM1AKDRFLT1FLT4MAPKAPK2
SCHEMBL7505010 0.78 KDR (0.58) KDRFLT1FLT4PDE4BMAP4K4
SCHEMBL7554511 0.78 KDR (0.51) KDM1AKDRFLT1FLT4GSK3B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6265403-B1 TYROSINE INHIBITORS MERCK & CO., INC. 2001-07-24 US disclosed
WO-2001040198-A2 MACROCYCLIC HYDROXAMIC ACID DERIVATIVES AND THEIR USE AS ANTIMICROBIAL AGENTS AVENTIS PHARMA S.A. (FR) 2001-06-07 WO disclosed